Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer
Petrova, Mila P., Eneva, Mariyana I., Arabadjiev, Jeliazko I., Conev, Nikolay V., Dimitrova, Eleonora G., Koynov, Krassimir D., Karanikolova, Teodora S., Valev, Spartak S., Gencheva, Radostina B., Zhbantov, Georgi A., Ivanova, Anika I., Sarbianova, Iva I., Timcheva, Constanta V., Donev, Ivan S.
Published in BioScience Trends (29.02.2020)
Published in BioScience Trends (29.02.2020)
Get full text
Journal Article
Antibiotic-Related Changes in Microbiome: The Hidden Villain behind Colorectal Carcinoma Immunotherapy Failure
Velikova, Tsvetelina, Krastev, Boris, Lozenov, Stefan, Gencheva, Radostina, Peshevska-Sekulovska, Monika, Nikolaev, Georgi, Peruhova, Milena
Published in International journal of molecular sciences (10.02.2021)
Published in International journal of molecular sciences (10.02.2021)
Get full text
Journal Article
PI3KCA mutation prevalence and outcome among patients with metastatic breast cancer in Bulgaria treated with first-line endocrine therapy
Gencheva, Radostina, Hadjidekova, Savina, Petrova, Mila, Krustev, Dimo, Kraleva, Petya, Zhbantov, Georgi, Conev, Nikolay Vladimirov, Stoyanov, Dragomir Svetozarov, Arabadjiev, Jeliazko Iliev, Tazimova, Eliz, Bachurska, Svitlana, Galev, Ivan, Eneva, Mariyana, Tsvetkova, Mariela, Staneva, Rada, Dimitrova, Eleonora, Hadjiev, Rossen, Donev, Ivan
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Abstract OT1-03-03: Investigating circulating lncRNAs in breast cancer patients on neoadjuvant systemic therapy
Krastev, Boris, Timcheva, Constanta, Valev, Spartak, Zhbantov, Georgi, Petrova, Mila, Karanikolova, Teodora, Gencheva, Radostina, Ivanova, Anika, Stoykov, Ivaylo, Stamenov, Georgi
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Get full text
Journal Article
High neutrophil to lymphocyte ratio as a predictor for hyperprogressive disease in patients with metastatic non-small cell lung cancer treated with pembrolizumab as a second line
Petrova, Milla, Eneva, Mariyana, Arabadjiev, Jeliazko Iliev, Conev, Nikolay Vladimirov, Dimitrova, Eleonora, Koynov, Krassimir Dimitrov, Karanikolova, Teodora, Valev, Spartak, Gencheva, Radostina, Zhbantov, Georgi, Ivanova, Anika, Sarbianova, Iva, Penkova, Polya, Timcheva, Konstanta, Donev, Ivan
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Sarcopenia as a negative predictive marker for treatment with pembrolizumab as a second line in patients with metastatic non-small cell lung cancer
Petrova, Milla, Valchev, Gerogi, Conev, Nikolay Vladimirov, Dimitrova, Eleonora, Robev, Bozhil, Boneva, Marsella, Pavlov, Boian, Minchev, Velko, Karanikolova, Teodora, Valev, Spartak, Gencheva, Radostina, Zhbantov, Georgi, Ivanova, Anika, Timcheva, Constanta, Donev, Ivan
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer
Petrova, Mila P., Eneva, Mariyana I., Arabadjiev, Jeliazko I., Conev, Nikolay V., Dimitrova, Eleonora G., Koynov, Krassimir D., Karanikolova, Teodora S., Valev, Spartak S., Gencheva, Radostina B., Zhbantov, Georgi A., Ivanova, Anika I., Sarbianova, Iva I., Timcheva, Constanta V., Donev, Ivan S.
Published in BioScience Trends (2020)
Published in BioScience Trends (2020)
Get full text
Journal Article